Prevention and treatment of heterotopic ossification after spinal cord injury

Short Title:
Prevention and treatment of heterotopic ossification after spinal cord injury
Model System:
SCI
Reference Type:
Journal Article
Accession No.:
J46887.
Journal:
Journal of Spinal Cord Medicine
Year, Volume, Issue, Page(s):
2004, vol. 27, issue 4, pp 376-382
Publication Website:
Abstract:
Article discusses the etiology, prevention, and clinical management of heterotopic ossification (HO) after spinal cord injury (SCI). Although the cause of HO after SCI remains unknown, trauma and overexpression of bone morphogenic proteins in traumatized soft tissue appear to play important roles. Preventive use of nonsteroidal antiinflammatory drugs (NSAIDs) reduces the incidence and severity of HO. Patients who develop symptoms of HO should have a bone scintigraphy. Those patients with positive scintigraphic findings of HO should be tested for serum creatine phosphokinase (CPK) and C-reactive protein (CRP) levels. Regardless of the CPK level, all patients with positive bone scintigraphy require NSAID treatment until serum CRP is normalized.
Author(s):
Banovac, Kresimir; Sherman, Andrew L.; Estores, Irene M.; Banovac, Filip
Author Address(es):

Some items may be available for document delivery from the National Rehabilitation Information Center. Make a note of the title and any accession number and contact NARIC at 800-346-2742 to request a copy. There is a charge for document delivery from the NARIC collection.